Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss of $0.14/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss of $0.14/Share

Aurinia Reports First Quarter 2019 Financial Results and Recent Operational Highlights

May 14, 2019 4:02 PM EDT

- Conference call and webcast to be hosted today at 4:30pm EDT -

VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company) today reported financial results for the first quarter ended March 31, 2019 and provided an update on recent operational highlights. Amounts, unless specified otherwise, are expressed in U.S. dollars.

First Quarter 2019 Highlights

Fully-enrolled AURORA Phase 3 trial in lupus nephritis (LN) continues on track with results anticipated in late 2019. Reported results from a Phase 2a Dry Eye study with... More